Faced with Biogen's Alzheimer's drug, panel would wield huge influence

Faced with Biogen's Alzheimer's drug, panel would wield huge influence

STAT Plus: With high stakes, eight experts would wield extraordinary influence on fate of Biogen’s Alzheimer’s drug

By DAMIAN GARDE

RUBY WALLAU FOR STAT

One prominent expert believes that any decision by the FDA to convene an advisory panel would be a telltale sign of the likely outcome.

READ MORE